Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Total 13F shares
-
45,275,292
-
Share change
-
+2,220,511
-
Total reported value
-
$1,410,431,002
-
Put/Call ratio
-
234%
-
Price per share
-
$31.13
-
Number of holders
-
129
-
Value change
-
+$61,178,963
-
Number of buys
-
63
-
Number of sells
-
62
Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q3 2024
As of 30 Sep 2024,
Immunocore Holdings plc - Ordinary shares (IMCR) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,275,292 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, T. Rowe Price Investment Management, Inc., RTW INVESTMENTS, LP, FMR LLC, PRIMECAP MANAGEMENT CO/CA/, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, ARMISTICE CAPITAL, LLC, GENERAL ATLANTIC, L.P., and Bellevue Group AG.
This page lists
129
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.